141 related articles for article (PubMed ID: 25741405)
21. HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study.
Alizadeh BZ; Njajou OT; Millán MR; Hofman A; Breteler MM; van Duijn CM
Neurobiol Aging; 2009 Feb; 30(2):330-2. PubMed ID: 17628213
[TBL] [Abstract][Full Text] [Related]
22. Meta-analyses of HFE variants in coronary heart disease.
Lian J; Xu L; Huang Y; Le Y; Jiang D; Yang X; Xu W; Huang X; Dong C; Ye M; Zhou J; Duan S
Gene; 2013 Sep; 527(1):167-73. PubMed ID: 23792061
[TBL] [Abstract][Full Text] [Related]
23. SNP and haplotype analysis reveals new HFE variants associated with iron overload trait.
Yang Y; Férec C; Mura C
Hum Mutat; 2011 Apr; 32(4):E2104-17. PubMed ID: 21412944
[TBL] [Abstract][Full Text] [Related]
24. [CCR5, CCR2, apoe, p53, ITGB3 and HFE gene polymorphism in Western Siberia long-livers].
Ivanoshchuk DE; Mikhaĭlova SV; Kulikov IV; Maksimov VN; Voevoda MI; Romashchenko AG
Adv Gerontol; 2012; 25(3):394-7. PubMed ID: 23289212
[TBL] [Abstract][Full Text] [Related]
25. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic expression of a novel C282Y/R226G compound heterozygous state in HFE hemochromatosis: molecular dynamics and biochemical studies.
Cézard C; Rabbind Singh A; Le Gac G; Gourlaouen I; Ferec C; Rochette J
Blood Cells Mol Dis; 2014 Jan; 52(1):27-34. PubMed ID: 23953397
[TBL] [Abstract][Full Text] [Related]
27. Candidate genes for age at menarche are associated with endometrial hyperplasia.
Ponomarenko I; Reshetnikov E; Polonikov A; Sorokina I; Yermachenko A; Dvornyk V; Churnosov M
Gene; 2020 Oct; 757():144933. PubMed ID: 32640302
[TBL] [Abstract][Full Text] [Related]
28. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
29. Haemochromatosis gene (HFE) polymorphisms and migraine: an association study.
Rainero I; Rubino E; Rivoiro C; Valfrè W; Binello E; Zampella E; De Martino P; Gentile S; Fenoglio P; Savi L; Gallone S; Pinessi L
Cephalalgia; 2007 Jan; 27(1):9-13. PubMed ID: 17212677
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.
Zetterberg M; Tasa G; Palmér MS; Juronen E; Teesalu P; Blennow K; Zetterberg H
Am J Ophthalmol; 2007 Jun; 143(6):1059-60. PubMed ID: 17524782
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women.
Freitas-Silva M; Pereira D; Coelho C; Bicho M; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2004 Nov; 155(1):42-6. PubMed ID: 15527901
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Yi YC; Chou PT; Chen LY; Kuo WH; Ho ES; Han CP; Yang SF
Clin Chem Lab Med; 2010 Mar; 48(3):337-44. PubMed ID: 20113256
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
36. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
37. Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.
Epplein M; Reed SD; Voigt LF; Newton KM; Holt VL; Weiss NS
Am J Epidemiol; 2008 Sep; 168(6):563-70; discussion 571-6. PubMed ID: 18682485
[TBL] [Abstract][Full Text] [Related]
38. Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department.
Vantyghem MC; Fajardy I; Dhondt F; Girardot C; D'Herbomez M; Danze PM; Rousseaux J; Wemeau JL
Eur J Endocrinol; 2006 Jun; 154(6):835-41. PubMed ID: 16728543
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E Genotypes in Patients with Prostate Cancer.
Yencilek F; Yilmaz SG; Yildirim A; Gormus U; Altinkilic EM; Dalan AB; Bastug Y; Turkmen S; Turkan S; Isbir T
Anticancer Res; 2016 Feb; 36(2):707-11. PubMed ID: 26851028
[TBL] [Abstract][Full Text] [Related]
40. Diabetes Mellitus Is Associated with Occult Cancer in Endometrial Hyperplasia.
Raffone A; Travaglino A; Saccone G; D'Alessandro P; Arduino B; Mascolo M; De Placido G; Insabato L; Zullo F
Pathol Oncol Res; 2020 Jul; 26(3):1377-1384. PubMed ID: 31203571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]